Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Endometrial Carcinoma (EC)”

27 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 27 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03835819
What this trial is testing

Mirvetuximab Soravtansine (IMGN853) and Pembrolizumab in Endometrial Cancer (EC)

Who this might be right for
Endometrial Cancer
Dana-Farber Cancer Institute 18
Testing effectiveness (Phase 2)Looking for participantsNCT06925724
What this trial is testing

Ivonescimab in People With Endometrial and Cervical Cancers

Who this might be right for
Endometrial CancerCervical Cancer
Memorial Sloan Kettering Cancer Center 50
Early research (Phase 1)Active Not RecruitingNCT07038369
What this trial is testing

ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

Who this might be right for
Advanced Solid TumorsBreast CancerBreast Carcinoma+24 more
Atavistik Bio, Inc 134
Not applicableLooking for participantsNCT06893861
What this trial is testing

Assessment of the Effectiveness of the Metabolomic Approach in Screening for Endometrial Cancer

Who this might be right for
Endometrial Carcinoma (EC)
National Cancer Institute, Naples 3,100
Post-approval studies (Phase 4)Not Yet RecruitingNCT06897527
What this trial is testing

Evaluate the Safety of Dostarlimab in Adult Participants in India With Recurrent or Advanced Endometrial Cancer (EC)

Who this might be right for
Neoplasms, Endometrial
GlaxoSmithKline 100
Very early researchEnrolling By InvitationNCT07316361
What this trial is testing

GYNORYLAQ™-VLINIVAL™: Ψ-Guided Personalized Neoantigen Peptide Vaccine for High-Risk Endometrial Cancer

Who this might be right for
Endometrial CarcinomaEndometrial Carcinoma Stage III
Biogenea Pharmaceuticals Ltd. 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT06129604
What this trial is testing

Pilot Window of Opportunity Trial (POET)

Who this might be right for
Colorectal Carcinoma (CRC)Endometrial Carcinoma (EC)
University of Oklahoma 10
Not applicableNot Yet RecruitingNCT07006103
What this trial is testing

Precision Medicine Applied to the Study of Endometrial Cancer: Application of NGS for Molecular Classification

Who this might be right for
Endometrial Cancer, Endometrial Neoplasm
Hospital Italiano de Buenos Aires 400
Not applicableStudy completedNCT06192017
What this trial is testing

Development of a Molecular Diagnostic Tool for Endometrial Cancer.

Who this might be right for
Endometrium Cancer
MiMARK Diagnostics, S.L. 1,950
Testing effectiveness (Phase 2)Study completedNCT03345485
What this trial is testing

Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors.

Who this might be right for
Small Cell Lung CancerSoft Tissue SarcomaTriple-negative Breast Cancer+2 more
Mundipharma Research Limited 71
Large-scale testing (Phase 3)Looking for participantsNCT03463252
What this trial is testing

Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC

Who this might be right for
Endometrial CancerAtypical Endometrial Hyperplasia
West China Second University Hospital 224
Early research (Phase 1)Active Not RecruitingNCT05277051
What this trial is testing

First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors

Who this might be right for
Neoplasms
GlaxoSmithKline 152
Not applicableLooking for participantsNCT07544680
What this trial is testing

Endometrial Cancer Vaginal Fluid Specimen Collection Study

Who this might be right for
Abnormal Uterine Bleeding (AUB)Endometrial CancerAtypical Endometrial Hyperplasia+2 more
Exact Sciences Corporation 4,200
Testing effectiveness (Phase 2)Study completedNCT00507741
What this trial is testing

Study of Vintafolide (MK-8109, EC145) in Participants With Advanced Ovarian and Endometrial Cancers (MK-8109-007, EC-FV-02)

Who this might be right for
Ovarian CancerEndometrial Cancer
Endocyte 49
Early research (Phase 1)Study completedNCT04474184
What this trial is testing

Development of a New Early Detection Test to Reduce Racial Disparities in Endometrial Cancer (EC) Death Rates

Who this might be right for
Endometrial Carcinoma
Mayo Clinic 33
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07605247
What this trial is testing

Tirzepatide in the Treatment of Endometrial Cancer

Who this might be right for
Endometrial Cancer
Rutgers, The State University of New Jersey 30
Testing effectiveness (Phase 2)Looking for participantsNCT07070518
What this trial is testing

Study of GV20-0251 in Participants With Solid Tumor Malignancies

Who this might be right for
Solid Tumor CancerAdult Refractory CancerEndometrial Carcinoma (EC)+6 more
GV20 Therapeutics 350
Testing effectiveness (Phase 2)Looking for participantsNCT06914297
What this trial is testing

TQB2450 Plus Progestin for Fertility-sparing Treatment in MMRd EC

Who this might be right for
Endometrial Cancer
Fudan University 10
Testing effectiveness (Phase 2)Looking for participantsNCT05669430
What this trial is testing

GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

Who this might be right for
Solid Tumor, AdultRefractory CancerEndometrial Carcinoma (EC)+4 more
GV20 Therapeutics 365
Large-scale testing (Phase 3)Active Not RecruitingNCT05611931
What this trial is testing

Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma

Who this might be right for
Endometrial Cancer
Karyopharm Therapeutics Inc 257
Load More Results